Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Daily use of emollients from birth may reduce atopic dermatitis in infants, but results are mixed.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

A cancer patient's hair became permanently curly after treatment with nivolumab.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Apremilast improved symptoms in patients with severe skin conditions.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

New mouse models of Pemphigus show severe symptoms and need better treatments.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.